Technical Analysis for LCI - Lannett Co Inc

Grade Last Price % Change Price Change
grade D 9.31 2.99% 0.27
LCI closed up 2.99 percent on Thursday, November 14, 2019, on 69 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Earnings due: Dec 1

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical LCI trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Up 3 Days in a Row Strength 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Buy Signal Bullish 2.99%
Lower Bollinger Band Walk Weakness 2.99%
Wide Bands Range Expansion 2.99%
Oversold Stochastic Weakness 2.99%
NR7 Range Contraction 3.67%
Lower Bollinger Band Walk Weakness 3.67%
Wide Bands Range Expansion 3.67%

Older signals for LCI ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of branded pharmaceutical products in the United States. It offers solid oral, extended release, topical, and oral solution finished dosage forms of drugs that address a range of therapeutic areas. The company provides its products for various medical indications comprising glaucoma, migraine, antibiotic, anesthetic, endometriosis, irritable bowel syndrome, obesity, congestive heart failure, antipsychotic, pain management, thyroid deficiency, dryness of the mouth, epilepsy, gout, bronchospasms, hypertension, and gallstone. Lannett Company, Inc. markets its products under the Diamox, Fioricet, Fiorinal, Fiorinal w/ Codeine #3, Cleocin, Danocrine, Bentyl, Tenuate, Dospan, Lanoxin, Adoxa, Periostat, Prolixin, Dilaudid, Levoxyl, Synthroid, Loxitane, Adipex-P, Fastin, Salagen, Mysoline, Benemid, Rifadin, Brethine, Dyazide, and Actigall brands. It also manufactures active pharmaceutical ingredients. The company sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. It has development and supply agreements with Azad Pharma AG, Swiss Caps of Switzerland, Pharma 2B, and the GC Group of Israel, as well as with Jerome Stevens Pharmaceuticals, Inc., Cerovene, and Summit Bioscience LLC. The company was founded in 1942 and is based in Philadelphia, Pennsylvania.
Health Pain Drugs Pharmaceutical Products Pharmaceutical Industry In China Obesity Pharmaceuticals Policy Pain Management Glaucoma Active Pharmaceutical Ingredients Hypertension Analgesics Epilepsy Pharmaceutical Manufacturers Irritable Bowel Syndrome Migraine Generic Drug Gout Congestive Heart Failure Drug Wholesalers Endometriosis Pharma Pharmaceutical Distributors
Is LCI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 15.52
52 Week Low 4.33
Average Volume 1,666,453
200-Day Moving Average 8.3543
50-Day Moving Average 11.9066
20-Day Moving Average 11.2365
10-Day Moving Average 10.54
Average True Range 0.7837
ADX 21.96
+DI 18.1746
-DI 33.1887
Chandelier Exit (Long, 3 ATRs ) 10.7689
Chandelier Exit (Short, 3 ATRs ) 11.061100000000001
Upper Bollinger Band 14.0397
Lower Bollinger Band 8.4333
Percent B (%b) 0.16
BandWidth 49.89454
MACD Line -0.6444
MACD Signal Line -0.277
MACD Histogram -0.3674
Fundamentals Value
Market Cap 347.11 Million
Num Shares 37.3 Million
EPS -0.02
Price-to-Earnings (P/E) Ratio -465.50
Price-to-Sales 1.32
Price-to-Book 1.49
PEG Ratio -0.90
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.14
Resistance 3 (R3) 10.12 9.82 10.00
Resistance 2 (R2) 9.82 9.61 9.83 9.95
Resistance 1 (R1) 9.57 9.48 9.70 9.59 9.91
Pivot Point 9.27 9.27 9.34 9.28 9.27
Support 1 (S1) 9.02 9.06 9.15 9.04 8.71
Support 2 (S2) 8.72 8.93 8.73 8.67
Support 3 (S3) 8.47 8.72 8.62
Support 4 (S4) 8.49